Enovis Corporation 0I1B.L Stock
Enovis Corporation Price Chart
Enovis Corporation 0I1B.L Financial and Trading Overview
Enovis Corporation stock price | 50.48 USD |
Previous Close | 53.09 USD |
Open | 0 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 65.6 USD |
Volume | 600 USD |
Avg. Volume | 147 USD |
Market Cap | N/A |
Beta (5Y Monthly) | 2.096478 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0I1B.L Valuation Measures
Enterprise Value | 3.34B USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.8711306 |
Enterprise Value/Revenue | 2.094 |
Enterprise Value/EBITDA | 16.964 |
Trading Information
Enovis Corporation Stock Price History
Beta (5Y Monthly) | 2.096478 |
52-Week Change | 0.10% |
S&P500 52-Week Change | 20.43% |
52 Week High | 65.6 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 58.69 USD |
200-Day Moving Average | 58.69 USD |
0I1B.L Share Statistics
Avg. Volume (3 month) | 147 USD |
Avg. Daily Volume (10-Days) | 133 USD |
Shares Outstanding | N/A |
Float | 49.64M |
Short Ratio | N/A |
% Held by Insiders | 8.82% |
% Held by Institutions | 98.53% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor | 0.333333:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -3.24% |
Operating Margin (ttm) | -0.56% |
Gross Margin | 57.27% |
EBITDA Margin | 12.34% |
Management Effectiveness
Return on Assets (ttm) | -0.086% |
Return on Equity (ttm) | -0.56% |
Income Statement
Revenue (ttm) | 1.59B USD |
Revenue Per Share (ttm) | 29.42 USD |
Quarterly Revenue Growth (yoy) | 8.20% |
Gross Profit (ttm) | 883.89M USD |
EBITDA | 196.72M USD |
Net Income Avi to Common (ttm) | -23472000 USD |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 21.9M USD |
Total Cash Per Share (mrq) | 0.4 USD |
Total Debt (mrq) | 357.41M USD |
Total Debt/Equity (mrq) | 10.37 USD |
Current Ratio (mrq) | 2.384 |
Book Value Per Share (mrq) | 63.188 |
Cash Flow Statement
Operating Cash Flow (ttm) | -33981000 USD |
Levered Free Cash Flow (ttm) | 321.78M USD |
Profile of Enovis Corporation
Country | United Kingdom |
State | DE |
City | Wilmington |
Address | 2711 Centerville Road |
ZIP | 19808 |
Phone | 302 252 9160 |
Website | https://www.enovis.com |
Industry | |
Sector(s) | |
Full Time Employees | 6800 |
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufacture and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.
Q&A For Enovis Corporation Stock
What is a current 0I1B.L stock price?
Enovis Corporation 0I1B.L stock price today per share is 50.48 USD.
How to purchase Enovis Corporation stock?
You can buy 0I1B.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Enovis Corporation?
The stock symbol or ticker of Enovis Corporation is 0I1B.L.
How many shares does Enovis Corporation have in circulation?
The max supply of Enovis Corporation shares is 0.
What is Enovis Corporation Price to Earnings Ratio (PE Ratio)?
Enovis Corporation PE Ratio is now.
What was Enovis Corporation earnings per share over the trailing 12 months (TTM)?
Enovis Corporation EPS is 0 USD over the trailing 12 months.